Catherine O’Connor

1.6k total citations
36 papers, 976 citations indexed

About

Catherine O’Connor is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Catherine O’Connor has authored 36 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Catherine O’Connor's work include Pancreatic and Hepatic Oncology Research (10 papers), Cancer Genomics and Diagnostics (8 papers) and Protease and Inhibitor Mechanisms (3 papers). Catherine O’Connor is often cited by papers focused on Pancreatic and Hepatic Oncology Research (10 papers), Cancer Genomics and Diagnostics (8 papers) and Protease and Inhibitor Mechanisms (3 papers). Catherine O’Connor collaborates with scholars based in United States, Ireland and United Kingdom. Catherine O’Connor's co-authors include Noel G. McElvaney, Tomás P. Carroll, Catherine M. Greene, Shane O’Neill, Allen G. Harbaugh, Sarah Michaels, Suzanne Chapin, C O'Flaherty, David R. Spriggs and Carol Aghajanian and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Catherine O’Connor

33 papers receiving 946 citations

Peers

Catherine O’Connor

ONCOL

PRM

SURGE

Brian J. Rybarczyk United States

Evan George United States

Christopher A. Smith United Kingdom

Ian Bennett Australia

Karen Parker United States

Louise Carter United Kingdom

Jerry Glenn United States

Roger D. Klein United States

Paul Shield Australia

Jerad M. Gardner United States

Brian J. Rybarczyk United States

Catherine O’Connor

152 ×0.4

ONCOL

98 ×0.4

144 ×0.7

PRM

90 ×0.6

SURGE

152 ×1.2

Citations per year, relative to Catherine O’Connor Catherine O’Connor (= 1×) peers Brian J. Rybarczyk

Countries citing papers authored by Catherine O’Connor

Since Specialization

Citations

This map shows the geographic impact of Catherine O’Connor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine O’Connor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine O’Connor more than expected).

Fields of papers citing papers by Catherine O’Connor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine O’Connor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine O’Connor. The network helps show where Catherine O’Connor may publish in the future.

Co-authorship network of co-authors of Catherine O’Connor

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine O’Connor. A scholar is included among the top collaborators of Catherine O’Connor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine O’Connor. Catherine O’Connor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Connor, Catherine, Mo Sun, R. M. Patel, et al.. (2025). CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance. Oncogene. 44(16). 1093–1105. 4 indexed citations

Keane, Fergus, Richard Tuli, Catherine O’Connor, et al.. (2024). Durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer (PDAC): Long-term outcomes and correlative insights.. Journal of Clinical Oncology. 42(16_suppl). 4174–4174.

Keane, Fergus, Joanne F. Chou, Henry Walch, et al.. (2024). Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease. JNCI Journal of the National Cancer Institute. 116(9). 1429–1438. 2 indexed citations

O’Connor, Catherine, Henry Walch, Andrea Gazzo, et al.. (2024). Somatic mismatch repair deficiency in pancreas cancer (PC): Immune checkpoint blockade (ICB) outcomes and exploratory genomic analyses.. Journal of Clinical Oncology. 42(16_suppl). 4144–4144. 3 indexed citations

Keane, Fergus, Catherine O’Connor, Wungki Park, Thomas Seufferlein, & Eileen M. O’Reilly. (2023). Pancreatic Cancer: BRCA Targeted Therapy and Beyond. Cancers. 15(11). 2955–2955. 14 indexed citations

Keane, Fergus, Fiyinfolu Balogun, Catherine O’Connor, et al.. (2023). Adjuvant modified FOLFIRINOX (mFFX) for resected pancreatic cancer (PDAC): Real world outcomes (RWO).. Journal of Clinical Oncology. 41(4_suppl). 685–685. 1 indexed citations

O’Connor, Catherine, et al.. (2023). Harnessing Patient Life Stories to Engage Medical Trainees in Strengthening Veteran-Provider Relationships. Medical Science Educator. 33(5). 1155–1163.

Tuli, Richard, Fergus Keane, Joshua D. Schoenfeld, et al.. (2023). A phase I/II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced (LA) and borderline resectable (BR) pancreatic cancer.. Journal of Clinical Oncology. 41(16_suppl). 4164–4164. 1 indexed citations

Keane, Fergus, Joshua D. Schoenfeld, Catherine O’Connor, et al.. (2023). A phase II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced pancreatic adenocarcinoma (LA PDAC).. Journal of Clinical Oncology. 41(4_suppl). 725–725. 1 indexed citations

10.

Park, Wungki, Catherine O’Connor, Chaitanya Bandlamudi, et al.. (2022). Clinico-genomic Characterization of ATM and HRD in Pancreas Cancer: Application for Practice. Clinical Cancer Research. 28(21). 4782–4792. 13 indexed citations

11.

Fereidoonnezhad, Behrooz, Catherine O’Connor, & Patrick McGarry. (2020). A new anisotropic soft tissue model for elimination of unphysical auxetic behaviour. Journal of Biomechanics. 111. 110006–110006. 28 indexed citations

12.

Molloy, Kevin, Craig P. Hersh, Valerie B. Morris, et al.. (2014). Clarification of the Risk of Chronic Obstructive Pulmonary Disease in α1-Antitrypsin Deficiency PiMZ Heterozygotes. American Journal of Respiratory and Critical Care Medicine. 189(4). 419–427. 118 indexed citations

13.

Carroll, Tomás P., Catherine O’Connor, Joseph McPartlin, et al.. (2011). The prevalence of alpha-1 antitrypsin deficiency in Ireland. Respiratory Research. 12(1). 91–91. 67 indexed citations

14.

Carroll, Tomás P., et al.. (2010). Evidence for Unfolded Protein Response Activation in Monocytes from Individuals with α-1 Antitrypsin Deficiency. The Journal of Immunology. 184(8). 4538–4546. 94 indexed citations

15.

Fusar‐Poli, Paolo, Pietro Landi, & Catherine O’Connor. (2009). Neurophysiological response to emotional faces with increasing intensity of fear: A skin conductance response study. Journal of Clinical Neuroscience. 16(7). 981–982. 9 indexed citations

16.

O’Connor, Catherine, et al.. (2009). Adherence to anti-retroviral therapy among HIV patients in Bangalore, India. AIDS Research and Therapy. 6(1). 7–7. 86 indexed citations

17.

Dee, Anne, et al.. (2008). Determining the cost of genital warts: a study from Ireland. Sexually Transmitted Infections. 85(5). 402–403. 10 indexed citations

18.

O’Connor, Catherine, et al.. (2006). HAART to Heart. AACN Clinical Issues Advanced Practice in Acute & Critical Care. 17(1). 18–29. 6 indexed citations

19.

Fennelly, D., Carol Aghajanian, F.L. Shapiro, et al.. (1997). Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer.. Journal of Clinical Oncology. 15(1). 187–192. 220 indexed citations

20.

Schmidt, Thomas, et al.. (1986). Upper gastrointestinal bleeding: predictors of outcome.. PubMed. 100(4). 765–73. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact